Clinical Trials Directory

Trials / Terminated

TerminatedNCT01309581

Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

Ketamine Anesthesia to Enhance Efficacy and Tolerability of Electroconvulsive Therapy in Patients With Unipolar or Bipolar Depression

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
James Murrough · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The primary objectives of this study are to investigate the potential for ketamine anesthesia to increase the antidepressant efficacy of Electroconvulsive therapy (ECT) and to decrease acute ECT-induced adverse cognitive effects.

Detailed description

Electroconvulsive therapy (ECT) is one of the most robust antidepressant treatments available. However, there is the potential for significant acute and longer term adverse cognitive effects with ECT and the antidepressant response requires multiple treatment sessions, increasing risk of adverse effects. Further, antidepressant response to ECT is often less than maximal and relapse is common. Growing preclinical and clinical evidence of the rapid-acting antidepressant properties of the anesthetic agent ketamine suggests the use of ketamine anesthesia as a strategy to increase rate of response and shorten treatment course in the administration of ECT. In addition, preclinical and clinical evidence suggests the potential of ketamine to decrease the adverse cognitive effects associated with ECT. The investigators propose a pilot study to measure both acute therapeutic efficacy and cognitive side effects of ECT using ketamine compared to methohexital in depressed patients. The investigators will also explore other parameters of ECT such as seizure duration and morphology, as well as hemodynamic and behavioral changes.

Conditions

Interventions

TypeNameDescription
DRUGKetamineKetamine 1-2 mg/kg IV as indicated for ECT
DRUGMethohexitalMethohexital 1 mg/kg IV as indicated for ECT

Timeline

Start date
2010-04-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2011-03-07
Last updated
2013-08-30
Results posted
2013-08-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01309581. Inclusion in this directory is not an endorsement.